EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS

被引：0
|
作者：
Meyer, S. [1 ]
Deuse, T. [2 ]
Baholli, L. [1 ]
Sattinger, E. [1 ]
Schlueter, M. [1 ]
von Stritzky, A. [1 ]
Reichenspurner, H. [2 ]
Costard-Jaeckle, A. [1 ]
机构：
[1] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Allgemeine & Intervent Kardiol, Hamburg, Germany
[2] Univ Herzzentrum Hamburg GmbH, Klin & Poliklin Herz & Gefasschirurg, Hamburg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [1] Influence of Everolimus-Based Immunosuppression on Infections in Heart Transplant Recipients
    Ohdah, S.
    Meyer, S.
    Schlueter, M.
    Deuse, T.
    Muellerleile, K.
    Reichenspurner, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S190 - S190
  • [2] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
  • [3] Everolimus-Based Immunosuppression in Liver Transplant Recipients
    Saliba, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2489 - 2489
  • [4] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression
    Peddi, V. Ram
    Marder, Bradley
    Gaite, Luis
    Oberholzer, Jose
    Goldberg, Ryan
    Pearson, Thomas
    Yang, Harold
    Allamassey, Lisa
    Polinsky, Martin
    Formica, Richard N.
    TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
  • [5] Psychiatric Morbidity in De Novo Heart Transplant Recipients on Everolimus-Based Immunosuppression
    Buerker, B. S.
    Malt, U. F.
    Gude, E.
    Gullestad, L.
    Relbo, A.
    Grov, I.
    Andreassen, A. K.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S288 - S289
  • [6] Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept plus Everolimus-Based Immunosuppression
    Peddi, V. R.
    Marder, B.
    Gaite, L.
    Oberholzer, J.
    Goldberg, R.
    Pearson, T.
    Yang, H.
    Allamassey, L.
    Gao, S.
    Polinsky, M.
    Formica, R. N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 922 - 922
  • [7] Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase
    Burker, B. S.
    Andersson, S.
    Gullestad, L.
    Gude, E.
    Relbo, A.
    Grov, I.
    Malt, U. F.
    Andreassen, A.
    Fiane, A. E.
    Haraldsen, I. R.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (06) : 595 - 596
  • [8] CONVERSION FROM CALCINEURIN INHIBITOR-BASED TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: LONG-TERM OUTCOME
    Dayangac, Murat
    TRANSPLANT INTERNATIONAL, 2017, 30 : 363 - 363
  • [9] Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.
    Hotta, K.
    Iwahara, N.
    Tanabe, T.
    Shinohara, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1083 - 1083
  • [10] Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Boillot, Olivier
    Giostra, Emiliano
    Dumortier, Jerome
    CLINICAL TRANSPLANTATION, 2011, 25 (04) : 660 - 669
12345